Trial Profile
Inhibitory efficacy in platelet aggregation and pharmacokinetics of single oral administration of 300mg clopidogrel and 20mg prasugrel
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Dec 2016
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Prasugrel (Primary)
- Indications Acute coronary syndromes; Ischaemic heart disorders
- Focus Pharmacodynamics
- 16 Dec 2016 New trial record
- 01 Nov 2016 Results published in the Clinical Pharmacology in Drug Development